The work by Westin et al. demonstrated that the reduction of the levels of superoxide in DC cells was not dependent of the localization of TERT in the mitochondria, but also p53/p21WAF/CIP-dependent process in the context of telomere shortening in cells from DC patients. The gene discussed is TERT; the disease is dyskeratosis congenita.